What is another name for fosinopril-HCTZ (fosinopril sodium and hydrochlorothiazide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Names for Fosinopril-HCTZ

Fosinopril sodium and hydrochlorothiazide is also known as Monopril-HCT, which is the brand name for this fixed-dose combination medication.

This combination medication consists of two active ingredients:

  1. Fosinopril sodium - an angiotensin-converting enzyme (ACE) inhibitor
  2. Hydrochlorothiazide (HCTZ) - a thiazide diuretic

Clinical Information About This Combination

This fixed-dose combination is used in the management of hypertension, where:

  • Fosinopril works by inhibiting the renin-angiotensin system, reducing vasoconstriction and sodium retention 1
  • HCTZ complements this action by increasing sodium and water excretion through the kidneys

Dosage Information

The typical dosage forms available include:

  • Initial dose: 10 mg fosinopril/12.5 mg HCTZ
  • Target dose: 20-40 mg fosinopril/12.5-25 mg HCTZ 1, 2

Clinical Considerations

  • This combination provides synergistic antihypertensive effects, as demonstrated in clinical studies 2
  • The dual route of elimination of fosinoprilat (the active metabolite of fosinopril) through both hepatic and renal pathways makes it particularly useful in patients with moderate renal impairment 3
  • Unlike some other ACE inhibitors that require dose adjustment in renal impairment, fosinopril may not require dosage modifications due to its compensatory elimination pathway 3

Important Precautions

  • ACE inhibitors including fosinopril are contraindicated in pregnancy 4
  • Monitor serum potassium and renal function within 3 months of starting this combination 4
  • If eGFR is <30 mL/min/m², a loop diuretic should be considered instead of HCTZ 1

This fixed-dose combination represents an effective option for hypertension management, particularly in patients who require multiple agents to achieve blood pressure control.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pharmacological Management of Hypertension and Heart Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.